Treatment to reduce edema

Details Treatment to reduce edema Treatment to reduce edema

1995-05-19

1997-05-20

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

435 12, A61K 3817, C07K 500, C07K 700

Patent

active

056312261

ABSTRACT:
Administration of a corticotropin-releasing factor (or a salt or analog thereof) decreases the leakage of blood components into tissues produced by various adverse medical conditions. Thus, treatments with corticotropin-releasing factor are useful in systemic inflammatory conditions.

REFERENCES:
patent: 3980778 (1976-09-01), Ayer et al.
patent: 4404198 (1983-09-01), Kelley
patent: 4415558 (1983-11-01), Vale, Jr. et al.
patent: 4489163 (1984-12-01), Rivier et al.
patent: 4517181 (1985-05-01), Ling et al.
patent: 4528189 (1985-07-01), Lederis et al.
patent: 4533654 (1985-08-01), Lederis et al.
patent: 4579844 (1986-04-01), Rovee et al.
patent: 4594329 (1986-06-01), Vale, Jr. et al.
patent: 4605642 (1986-08-01), Rivier et al.
patent: 4801612 (1989-01-01), Wei et al.
patent: 5137871 (1992-08-01), Wei
patent: 5488033 (1996-01-01), Wei

Affiliated with

Also associated with

Rating

Treatment to reduce edema does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment to reduce edema, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment to reduce edema will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1723905